[go: up one dir, main page]

DK1778193T3 - Farmaceutisk partikelsammensætning til udstrakt frigivelse omfattende venlafaxin - Google Patents

Farmaceutisk partikelsammensætning til udstrakt frigivelse omfattende venlafaxin

Info

Publication number
DK1778193T3
DK1778193T3 DK05768606T DK05768606T DK1778193T3 DK 1778193 T3 DK1778193 T3 DK 1778193T3 DK 05768606 T DK05768606 T DK 05768606T DK 05768606 T DK05768606 T DK 05768606T DK 1778193 T3 DK1778193 T3 DK 1778193T3
Authority
DK
Denmark
Prior art keywords
venlafaxine
release pharmaceutical
particle composition
pharmaceutical particle
extensive release
Prior art date
Application number
DK05768606T
Other languages
English (en)
Inventor
Robert Pisek
Silvo Zupancic
Zakelj Mojca Segula
Original Assignee
Krka Tovarna Zdravil D D Novo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Krka Tovarna Zdravil D D Novo filed Critical Krka Tovarna Zdravil D D Novo
Application granted granted Critical
Publication of DK1778193T3 publication Critical patent/DK1778193T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/167—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface
    • A61K9/1676—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface having a drug-free core with discrete complete coating layer containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5084—Mixtures of one or more drugs in different galenical forms, at least one of which being granules, microcapsules or (coated) microparticles according to A61K9/16 or A61K9/50, e.g. for obtaining a specific release pattern or for combining different drugs

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Neurology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Emergency Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK05768606T 2004-07-28 2005-07-27 Farmaceutisk partikelsammensætning til udstrakt frigivelse omfattende venlafaxin DK1778193T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102004036641A DE102004036641A1 (de) 2004-07-28 2004-07-28 Verzögert freisetzende pharmazeutische Zusammensetzung, die Venlafaxin enthält
PCT/EP2005/008149 WO2006010605A2 (en) 2004-07-28 2005-07-27 Sustained release pharmaceutical particulate composition comprising venlafaxine

Publications (1)

Publication Number Publication Date
DK1778193T3 true DK1778193T3 (da) 2008-02-04

Family

ID=35106687

Family Applications (1)

Application Number Title Priority Date Filing Date
DK05768606T DK1778193T3 (da) 2004-07-28 2005-07-27 Farmaceutisk partikelsammensætning til udstrakt frigivelse omfattende venlafaxin

Country Status (16)

Country Link
EP (1) EP1778193B1 (da)
AT (1) ATE381925T1 (da)
CY (1) CY1107187T1 (da)
DE (2) DE102004036641A1 (da)
DK (1) DK1778193T3 (da)
EA (1) EA009957B1 (da)
ES (1) ES2299061T3 (da)
HR (1) HRP20080007T3 (da)
NO (1) NO20071139L (da)
PL (1) PL1778193T3 (da)
PT (1) PT1778193E (da)
RS (1) RS50572B (da)
SI (1) SI1778193T1 (da)
UA (1) UA83437C2 (da)
WO (1) WO2006010605A2 (da)
ZA (1) ZA200701554B (da)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10722458B2 (en) * 2011-12-02 2020-07-28 Pegasus Laboratories, Inc. Amphipathic lipid-based sustained release compositions

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL146462A (en) * 2001-11-13 2015-02-26 Lycored Bio Ltd Prolonged-release preparations containing as an active compound and analapaxin hydrochloride
WO2003055475A1 (en) * 2002-01-03 2003-07-10 Lek Pharmaceutical And Chemical Company D.D. Controlled release pharmaceutical formulation containing venlafaxine
AU2003236947A1 (en) * 2002-06-07 2003-12-22 Ranbaxy Laboratories Limited Modified release, multiple unit drug delivery systems
AU2003278549A1 (en) * 2002-11-28 2004-06-18 Themis Laboratories Private Limited Process for manufacturing sustained release microbeads containing venlafaxine hci

Also Published As

Publication number Publication date
PT1778193E (pt) 2008-03-10
DE602005004033T2 (de) 2009-01-02
ES2299061T3 (es) 2008-05-16
RS50572B (sr) 2010-05-07
WO2006010605A3 (en) 2006-09-21
EA009957B1 (ru) 2008-04-28
PL1778193T3 (pl) 2008-05-30
ZA200701554B (en) 2008-05-28
WO2006010605A2 (en) 2006-02-02
EP1778193A2 (en) 2007-05-02
ATE381925T1 (de) 2008-01-15
SI1778193T1 (sl) 2008-06-30
DE602005004033D1 (de) 2008-02-07
DE102004036641A1 (de) 2006-03-23
CY1107187T1 (el) 2012-10-24
UA83437C2 (uk) 2008-07-10
NO20071139L (no) 2007-02-28
EA200700159A1 (ru) 2007-06-29
EP1778193B1 (en) 2007-12-26
HRP20080007T3 (hr) 2008-01-31

Similar Documents

Publication Publication Date Title
WO2008006716A3 (en) Improvements relating to pharmaceutical compositions
WO2009154777A3 (en) Process for preparing and drying solid rasagiline base
MY150087A (en) Composition and microsphere for controlled- release of exendin, and method of preparing the same
WO2005117843A3 (en) Sustained release preparations
NO20070871L (no) Multipartikkelformulering
EP2584043A3 (en) Anti-glypican 3 antibody having improved kinetics in plasma
WO2009024989A3 (en) A novel hydrated form of erlotinib free base and a process for preparation of erlotinib hydrochloride polymorph form a substantially free of polymorph form b
ATE501223T1 (de) Wässrige dispersionen aus polymerkapselpartikeln, zugehörige beschichtungszusammensetzungen und beschichtete substrate
HRP20130424T4 (hr) Postupci upotrebe sastava aminopiridina s odgođenim oslobađanjem
WO2006089674A3 (en) Tablets with improved drug substance dispersibility
JP2009515210A5 (da)
WO2009080628A3 (en) Kit comprising an alginate and a complexing agent in the form of a water-soluble salt
WO2007130438A3 (en) Solid dosage formulations
WO2009033112A3 (en) Highly porous, large polymeric particles and methods of preparation and use
WO2009053576A3 (fr) Composition d'enrobage comprenant du polydextrose, procede pour sa preparation et utilisation pour enrober les formes solides ingerables
WO2009007992A3 (en) Pharmaceutical composition produced by microprecipitation
DK1890698T3 (da) Fremgangsmåde til fremstilling af et nikotinafgivelses-produkt
NO20064934L (no) Fremgangsmate for fremstilling av et fast, farmasoytisk preparat
JP2009519849A5 (da)
WO2010020799A3 (en) Compositions for the treatment of neoplastic diseases
JP2008521971A5 (da)
TW200621307A (en) Solid dispersion composition of pranlukast with improved bioavailibility and the method of preparing the solid dispersion
EP2551266A8 (en) 2',2-dithiazol non-nucleoside compounds, preparation methods, pharmaceutical compositions and uses as hepatitis virus inhibitors thereof
DK1778193T3 (da) Farmaceutisk partikelsammensætning til udstrakt frigivelse omfattende venlafaxin
MX2008001560A (es) Nuevos compuestos analogos de la camptotecina, un procedimiento para su preparacion y composiciones farmaceuticas que los contienen.